| Neil Joseph Murphy, MD | |
|
4320 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, AK 99508-5925 | |
| (907) 729-3971 | |
| (907) 729-1542 |
| Full Name | Neil Joseph Murphy |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 42 Years |
| Location | 4320 Diplomacy Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598878019 | NPI | - | NPPES |
| MD2240 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 2294 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alaska Native Medical Center | Anchorage, AK | Hospital |
| Maniilaq Health Center | Kotzebue, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alaska Native Tribal Health Consortium | 6709780265 | 457 |
| Southcentral Foundation | 5496663627 | 112 |
News Archive
An industry-first technology developed by Loughborough University has the potential to significantly cut nitrogen oxide (NOx) emissions in diesel engines.
A study in the Jan. 1 issue of the journal Sleep indicates that the indirect costs of untreated insomnia are significantly greater than the direct costs associated with its treatment.
BodyCap, a company specialized in miniaturized wireless monitoring devices for e-health applications, today announces that it has obtained the medical CE mark for e-Celsius from the LNE Gmed certifying organization.
Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, will present data from three Phase II clinical trials highlighting the clinical potential of its unique phosphatidylserine -targeting antibody bavituximab for the treatment of solid tumors.
Recent research has established associations between certain environmental factors, including eating a western diet and being sedentary, with an increased susceptibility to Alzheimer's disease. In fact, it is estimated that a combination of diet and inactivity contributes to as many as 25% of Alzheimer's cases. Nonetheless, little is known about the exact disease mechanisms and how or why this increasingly common middle-age lifestyle can play such a big role in subsequent cognitive function.
› Verified 1 days ago
| Entity Name | Alaska Native Tribal Health Consortium |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772 |
News Archive
An industry-first technology developed by Loughborough University has the potential to significantly cut nitrogen oxide (NOx) emissions in diesel engines.
A study in the Jan. 1 issue of the journal Sleep indicates that the indirect costs of untreated insomnia are significantly greater than the direct costs associated with its treatment.
BodyCap, a company specialized in miniaturized wireless monitoring devices for e-health applications, today announces that it has obtained the medical CE mark for e-Celsius from the LNE Gmed certifying organization.
Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, will present data from three Phase II clinical trials highlighting the clinical potential of its unique phosphatidylserine -targeting antibody bavituximab for the treatment of solid tumors.
Recent research has established associations between certain environmental factors, including eating a western diet and being sedentary, with an increased susceptibility to Alzheimer's disease. In fact, it is estimated that a combination of diet and inactivity contributes to as many as 25% of Alzheimer's cases. Nonetheless, little is known about the exact disease mechanisms and how or why this increasingly common middle-age lifestyle can play such a big role in subsequent cognitive function.
› Verified 1 days ago
| Entity Name | Maniilaq Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861698805 PECOS PAC ID: 6103881792 Enrollment ID: O20041123000372 |
News Archive
An industry-first technology developed by Loughborough University has the potential to significantly cut nitrogen oxide (NOx) emissions in diesel engines.
A study in the Jan. 1 issue of the journal Sleep indicates that the indirect costs of untreated insomnia are significantly greater than the direct costs associated with its treatment.
BodyCap, a company specialized in miniaturized wireless monitoring devices for e-health applications, today announces that it has obtained the medical CE mark for e-Celsius from the LNE Gmed certifying organization.
Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, will present data from three Phase II clinical trials highlighting the clinical potential of its unique phosphatidylserine -targeting antibody bavituximab for the treatment of solid tumors.
Recent research has established associations between certain environmental factors, including eating a western diet and being sedentary, with an increased susceptibility to Alzheimer's disease. In fact, it is estimated that a combination of diet and inactivity contributes to as many as 25% of Alzheimer's cases. Nonetheless, little is known about the exact disease mechanisms and how or why this increasingly common middle-age lifestyle can play such a big role in subsequent cognitive function.
› Verified 1 days ago
| Entity Name | Tanana Chiefs Conference |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821201278 PECOS PAC ID: 9537050109 Enrollment ID: O20050111000954 |
News Archive
An industry-first technology developed by Loughborough University has the potential to significantly cut nitrogen oxide (NOx) emissions in diesel engines.
A study in the Jan. 1 issue of the journal Sleep indicates that the indirect costs of untreated insomnia are significantly greater than the direct costs associated with its treatment.
BodyCap, a company specialized in miniaturized wireless monitoring devices for e-health applications, today announces that it has obtained the medical CE mark for e-Celsius from the LNE Gmed certifying organization.
Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, will present data from three Phase II clinical trials highlighting the clinical potential of its unique phosphatidylserine -targeting antibody bavituximab for the treatment of solid tumors.
Recent research has established associations between certain environmental factors, including eating a western diet and being sedentary, with an increased susceptibility to Alzheimer's disease. In fact, it is estimated that a combination of diet and inactivity contributes to as many as 25% of Alzheimer's cases. Nonetheless, little is known about the exact disease mechanisms and how or why this increasingly common middle-age lifestyle can play such a big role in subsequent cognitive function.
› Verified 1 days ago
| Entity Name | Southcentral Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780614263 PECOS PAC ID: 5496663627 Enrollment ID: O20051027000416 |
News Archive
An industry-first technology developed by Loughborough University has the potential to significantly cut nitrogen oxide (NOx) emissions in diesel engines.
A study in the Jan. 1 issue of the journal Sleep indicates that the indirect costs of untreated insomnia are significantly greater than the direct costs associated with its treatment.
BodyCap, a company specialized in miniaturized wireless monitoring devices for e-health applications, today announces that it has obtained the medical CE mark for e-Celsius from the LNE Gmed certifying organization.
Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, will present data from three Phase II clinical trials highlighting the clinical potential of its unique phosphatidylserine -targeting antibody bavituximab for the treatment of solid tumors.
Recent research has established associations between certain environmental factors, including eating a western diet and being sedentary, with an increased susceptibility to Alzheimer's disease. In fact, it is estimated that a combination of diet and inactivity contributes to as many as 25% of Alzheimer's cases. Nonetheless, little is known about the exact disease mechanisms and how or why this increasingly common middle-age lifestyle can play such a big role in subsequent cognitive function.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Neil Joseph Murphy, MD 4501 Diplomacy Dr, Anchorage, AK 99508-5919 Ph: (907) 729-3300 | Neil Joseph Murphy, MD 4320 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, AK 99508-5925 Ph: (907) 729-3971 |
News Archive
An industry-first technology developed by Loughborough University has the potential to significantly cut nitrogen oxide (NOx) emissions in diesel engines.
A study in the Jan. 1 issue of the journal Sleep indicates that the indirect costs of untreated insomnia are significantly greater than the direct costs associated with its treatment.
BodyCap, a company specialized in miniaturized wireless monitoring devices for e-health applications, today announces that it has obtained the medical CE mark for e-Celsius from the LNE Gmed certifying organization.
Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, will present data from three Phase II clinical trials highlighting the clinical potential of its unique phosphatidylserine -targeting antibody bavituximab for the treatment of solid tumors.
Recent research has established associations between certain environmental factors, including eating a western diet and being sedentary, with an increased susceptibility to Alzheimer's disease. In fact, it is estimated that a combination of diet and inactivity contributes to as many as 25% of Alzheimer's cases. Nonetheless, little is known about the exact disease mechanisms and how or why this increasingly common middle-age lifestyle can play such a big role in subsequent cognitive function.
› Verified 1 days ago
Dr. Wendy Sue Cruz, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2741 Debarr Rd Ste C205, Anchorage, AK 99508 Phone: 907-279-2273 Fax: 907-258-7705 | |
Dr. James Thomas Barber Jr., D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3831 Piper St Ste Sll020, Anchorage, AK 99508 Phone: 907-212-3470 Fax: 907-212-3474 | |
Dr. Natalie Dawn Ward, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3260 Providence Dr, Ste. #425, Anchorage, AK 99508 Phone: 907-561-7111 Fax: 907-770-7891 | |
Tania H Hall, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3260 Providence Dr, Ste 322, Anchorage, AK 99508 Phone: 907-563-5151 Fax: 907-563-6278 | |
Anne Gray, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4141 Ambassador Dr, Anchorage, AK 99508 Phone: 907-729-1542 | |
Mrs. Kristin M Murray, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4115 Lake Otis Pkwy, Anchorage, AK 99508 Phone: 907-563-7228 Fax: 907-563-6278 | |
Kathryn Murphy, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4320 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-3116 |